FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Thank You

By adding your name in honor of MDA’s 75th anniversary, you raised $5 for people living with neuromuscular diseases.

Your support fuels the next chapter of progress in research, care, and advocacy!